Related Experiment Video

Updated: Jul 4, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Mechanisms of neurodegeneration in Huntington's disease

Joana M Gil1, Ana Cristina Rego

  • 1Island Medical Program, Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.

The European Journal of Neuroscience
|July 1, 2008
PubMed

Insights

Huntington's disease (HD) stems from expanded CAG repeats in the huntingtin gene, causing neuronal death. Understanding HD pathogenesis mechanisms is key to developing effective treatments for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by cytosine-adenine-guanine (CAG) repeat expansion in the huntingtin gene.
  • This genetic mutation leads to neuronal loss in the striatum and cortex and the formation of mutant huntingtin inclusions.
  • Huntingtin protein dysfunction involves loss-of-function and toxic gain-of-function mechanisms, disrupting critical cellular pathways.

Purpose of the Study:

  • To review the complex mechanisms contributing to Huntington's disease pathogenesis.
  • To provide a comprehensive overview of the molecular and cellular disruptions in HD.
  • To highlight the need for a deeper understanding to identify novel therapeutic targets.

Main Methods:

  • Literature review of scientific articles on Huntington's disease.
  • Analysis of genetic, molecular, and cellular mechanisms implicated in HD.
  • Synthesis of information on protein trafficking, signaling, transcriptional regulation, and cell death pathways.

Main Results:

  • CAG repeat expansion in the huntingtin gene is the primary cause of HD.
  • Multiple cellular dysfunctions, including excitotoxicity, metabolic impairment, and oxidative stress, contribute to neurodegeneration.
  • Both loss of normal huntingtin function and toxic gain of mutant huntingtin function play roles in disease progression.

Conclusions:

  • Huntington's disease pathogenesis involves a complex interplay of genetic and cellular factors.
  • A thorough understanding of these mechanisms is crucial for developing effective therapeutic strategies.
  • Further research into HD pathogenesis will facilitate the discovery of treatments for this incurable neurodegenerative disease.

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...